Cleveland Clinic Cardiovascular Update 2025

Name: Cleveland Clinic Cardiovascular Update 2025 - DrMedciene
SKU: MED-AMB-00881
Price: 25.00 USD
Availability: InStock

$25.00

This Product is shared via google drive download link, So please share your correct Gmail id while placing the order .Please note that there are no CME points or certificate associated with this course Samples for Courses Can be found here : Free Samples Here!

50 videos, size: 3.86 GB

SKU: MED-AMB-00881 Categories: Cardiology, Critical Care \ Emergency medicine, Radiology cousres Tags: CARDIOLOGY, Critical Care Emergency medicine, RADIOLOGY

Description

Cleveland Clinic Cardiovascular Update 2025

Cleveland Clinic
Cardiovascular Update

Session 1: Prevention and Management of Cardiovascular Risk, Part 1
Tools in CVD Prevention and Risk Management: To Test or Not to Test? Lp(a),apoB, Non HDL-C	Dennis Bruemmer, MD, PhD
Statin Initiation for Primary Prevention Among Statin Naïve Adults and Reasons for Nonadherence	Vikas Sunder, MD
When Statins Are Not Enough – Non-statin Lipid Lowering Therapies to Manage Residual Risk	Ashish Sarraju, MD
Managing Anti-Hyperglycemic and CV Risk Reduction Agents in Patients With Diabetes: SGLT2i or GLP1RA or Both?	Dennis Bruemmer, MD, PhD
Weight Loss Pharmacotherapy: Utilizing Current Therapies and Exploring the Next Generation of Weight Loss Medications	Steve Nissen, MD
Keto, Low Carb, Plant Based, IF: Controversies in the Evidence for the “Best “Diet: What is the Evidence and How to Apply in Clinical Practice	Julia Zumpano, RD, LD
Old and Evolving Strategies for Treatment-Resistant Hypertension	Luke Laffin, MD
Social Determinants of Health and Cardiovascular Disease: Current State and Future Directions	Lee Kirksey, MD
Panel Discussion/Q&A	Session Faculty
Session 2: Prevention and Management of Cardiovascular Risk, Part 2
Hormone Therapy and Heart Health: Debunking Myths, Embracing Evidence	Luke Laffin, MD
The Intersection of Cardiovascular Disease and Chronic Kidney Disease: Strategies for Reducing Cardiovascular Risk	Crystal Gadegbeku, MD
Who Should Get a CAC? How Often? How to Use the Results to Assess Risk?	Milind Desai, MD
Management of CV Issues in the Elderly: Geriatric Cardiology	Ardeshir Hashmi, MD
Population Health Management: Interventions to Control Cardiovascular Disease Risk Factors: Current Status	LeRoi Hicks, MD
Panel Discussion/Q&A	Session Faculty
Session 3: Special Populations
Cardiac Disease Remains the Leading Cause of Mortality in Women: What are we Doing to Address This?	Vikas Sunder, MD
Cardiovascular Disease and Pregnancy: Optimizing Maternal and Fetal Health	Deirdre Mattina, MD
Competitive Sports Participation in Athletes with Heart Disease: Evaluation and Management	Tamanna Singh, MD
Cardio-oncology: Optimizing the Balance Between Cancer Outcomes and Cardiac Success	Patrick Collier, MD, PhD
Panel Discussion/Q&A	Session Faculty
Session 4: Essentials of Cardiovascular Disease
Role of Advanced Imaging for Ischemic Heart Disease: CT, CMR, Nuclear and Advanced Echocardiography	Saberio Lo Presti Vega, MD
Creating a Pathway for the Management of Stable Angina in Your Clinic: Structured Risk Assessment and Clinical Decision Making	Ben Alencherry, MD
ANOCA, INOCA, MINOCA: What Does It All Mean? Diagnostic Testing and Therapeutic Management	Khalid Ziada, MD
How Do I Manage my Post MI Patient (Including DAPT Guidelines/Duration/CardiacRehab)	Venu Menon, MD
Cardiac Rehab: Why it is Critical and How Can We Improve Access and Compliance?	Erik Van Iterson, PhD, MS
Peripheral Artery Disease: Assessment and Clinical Decision Making	Lee Kirksey, MD
Panel Discussion/Q&A	Session Faculty
Session 5: Structural Heart Disease
Aortic Stenosis: Diagnosis and Management in the Modern Era	Samir Kapadia, MD
MR: How to Diagnose and Manage Mitral Valve Disease: When to Refer? What are the Options	L. Leonardo Rodriguez, MD
What to Know About the Natural History of Tricuspid Regurgitation: Current and Future Management Strategies	Amar Krishnaswamy, MD
Bicuspid and Aneurysm-Associated Aortic Valve Disease: Timing of Intervention and the Role of Family Screening	Milind Desai, MD
Guidelines for Anticoagulation Following Structural Heart Therapies	Grant Reed, MD, MSc
Hypertrophic Cardiomyopathy: Co-management in the Era of Emerging Precision Therapies	Milind Desai, MD
Panel Discussion/Q&A	Session Faculty
Session 6: Heart Failure
Heart Failure Stages, Phenotypes and Diagnosis and How to Screen for HF in the Primary Care Setting	Randall Starling, MD
HFrEF: Essentials of Guideline Directed Medical Therapy Initiation and Titration	Amanda Vest, MBBS
Managing Comorbidities in HF: Frailty, Anemia, Sleep Apnea, AF, Obesity	Karlee Hoffman, DO
Essentials of Diagnosis and Management for HFpEF	Sanjeeb Bhattacharya, MD
Diagnosis and Management of Transthyretin Amyloid Cardiomyopathy (ATTR-CM)	Mazen Hanna, MD
Strategies to Enhance GDMT Implementation and Adherence	M. Trejeeve Martyn, MD
Managing Long Term LVADs and Transplant Recipients in the Community Setting	Ike Okwuosa, MD
The Importance of Collaboration Between EP and HF: CRT and Novel Pacing	Niraj Varma, MD, PhD
Panel Discussion/Q&A	Session Faculty
Session 7: Heart Rhythm
Diagnosis and Management of New-Onset Atrial Fibrillation	Mohamed Kanj, MD
AF and Left Atrial Appendage Closure: Current and Future Directions	Mohamed Kanj, MD
What I Need to Know to Evaluate and Manage the Patient With PVCs and SVT	Pasquale Santangeli, MD, PhD
Evaluation and Management of Syncope in the Young Adult	Kenneth Mayuga, MD
Follow-Up of Pacemakers and ICDs For the Non-Electrophysiologist	Kevin F. Kwaku, MD, PhD
Wearables for Arrhythmia Care: Current Challenges and Future Prospects	Niraj Varma, MD, PhD
Panel Discussion/Q&A	Session Faculty